NASDAQ · Analyst Forecast

Korsana Biosciences, Inc. (KRSA) Stock Forecast & Price Target

$32.50 NASDAQ: KRSA Market Cap $152.14M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 14, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Korsana Biosciences, Inc. (KRSA), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Korsana Biosciences, Inc., analysts forecast revenue falling from $1.10M in 2025 to $88,062 in 2030; the average estimate for 2030 earnings per share is −$3.03; 5 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$32.50
Consensus targetThe average of the price targets analysts have published.$51.20
Median targetThe middle target, less affected by a single outlier.$44.00
Highest targetThe most optimistic published target.$70.00
Lowest targetThe most pessimistic published target.$43.00
Difference from priceHow far the consensus target sits from today’s price.+57.5%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$1.10M$1.10M$1.10M1
2026$1.10M$1.10M$1.10M5
2027$586,141$586,141$586,1415
2028$311,601$311,601$311,6014
2029$165,651$165,651$165,6512
2030$88,062$88,062$88,0622

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$9.38−$9.38−$9.381
2026−$9.51−$6.92−$4.335
2027−$4.15−$3.66−$3.015
2028−$3.72−$3.20−$2.874
2029−$3.46−$3.46−$3.462
2030−$3.03−$3.03−$3.032

Korsana Biosciences, Inc. (KRSA) forecast — frequently asked questions

What is the analyst price target for Korsana Biosciences, Inc.?

Analysts covering Korsana Biosciences, Inc. (KRSA) have a consensus price target of $51.20, 57.5% above the current price of $32.50. Published targets range from $43.00 to $70.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Korsana Biosciences, Inc.'s earnings?

The average analyst estimate for Korsana Biosciences, Inc. (KRSA) earnings per share in 2030 is -3.03, with individual estimates between -3.03 and -3.03.

How much revenue is Korsana Biosciences, Inc. expected to make?

Analysts forecast Korsana Biosciences, Inc. (KRSA) revenue of $88,062 in 2030, based on 2 published estimates.

How many analysts cover KRSA?

5 analysts contribute estimates for Korsana Biosciences, Inc. (KRSA). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.